190 related articles for article (PubMed ID: 9114040)
1. Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.
Waisman A; Ruiz PJ; Israeli E; Eilat E; Könen-Waisman S; Zinger H; Dayan M; Mozes E
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4620-5. PubMed ID: 9114040
[TBL] [Abstract][Full Text] [Related]
2. A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is also a dominant T-cell epitope in (NZBXNZW)F1 lupus-prone mice.
Brosh N; Dayan M; Fridkin M; Mozes E
Immunol Lett; 2000 Apr; 72(1):61-8. PubMed ID: 10789683
[TBL] [Abstract][Full Text] [Related]
3. The role of the 16/6 idiotype network in the induction and manifestations of systemic lupus erythematosus.
Waisman A; Mendlovic S; Ruiz PJ; Zinger H; Meshorer A; Mozes E
Int Immunol; 1993 Oct; 5(10):1293-300. PubMed ID: 8268135
[TBL] [Abstract][Full Text] [Related]
4. Modulation of autoreactive responses of peripheral blood lymphocytes of patients with systemic lupus erythematosus by peptides based on human and murine anti-DNA autoantibodies.
Sthoeger ZM; Dayan M; Tcherniack A; Green L; Toledo S; Segal R; Elkayam O; Mozes E
Clin Exp Immunol; 2003 Feb; 131(2):385-92. PubMed ID: 12562403
[TBL] [Abstract][Full Text] [Related]
5. A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogs.
Brosh N; Zinger H; Fridkin M; Mozes E
Cell Immunol; 2000 Oct; 205(1):52-61. PubMed ID: 11078607
[TBL] [Abstract][Full Text] [Related]
6. Variable regions of two murine antibodies that bind the SLE associated 16/6 idiotype.
Waisman A; Ruiz PJ; Mozes E
Lupus; 1996 Aug; 5(4):279-87. PubMed ID: 8869899
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus-related autoantibody production in mice is determined by bone marrow-derived cells.
Levite M; Zinger H; Mozes E; Reisner Y
Bone Marrow Transplant; 1993 Sep; 12(3):179-83. PubMed ID: 8241973
[TBL] [Abstract][Full Text] [Related]
8. Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibody.
Brosh N; Eilat E; Zinger H; Mozes E
Immunology; 2000 Feb; 99(2):257-65. PubMed ID: 10692045
[TBL] [Abstract][Full Text] [Related]
9. The role of the idiotypic network in the induction of experimental systemic lupus erythematosus.
Mozes E; Brocke S; Shoenfeld Y; Mendlovic S
J Cell Biochem; 1989 Jun; 40(2):173-81. PubMed ID: 2788655
[TBL] [Abstract][Full Text] [Related]
10. Immune response of SLE patients to peptides based on the complementarity determining regions of a pathogenic anti-DNA monoclonal antibody.
Dayan M; Segal R; Sthoeger Z; Waisman A; Brosh N; Elkayam O; Eilat E; Fridkin M; Mozes E
J Clin Immunol; 2000 May; 20(3):187-94. PubMed ID: 10941826
[TBL] [Abstract][Full Text] [Related]
11. Treatment of induced murine SLE with a peptide based on the CDR3 of an anti-DNA antibody reverses the pattern of pathogenic cytokines.
Brosh N; Zinger H; Mozes E
Autoimmunity; 2002 May; 35(3):211-9. PubMed ID: 12389646
[TBL] [Abstract][Full Text] [Related]
12. A peptide based on the CDR1 of a pathogenic anti-DNA antibody is more efficient than its analogs in inhibiting autoreactive T cells.
Eilat E; Fridkin M; Mozes E
Immunobiology; 2000 Nov; 202(4):383-93. PubMed ID: 11131154
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA.
Herkel J; Erez-Alon N; Mimran A; Wolkowicz R; Harmelin A; Ruiz P; Rotter V; Cohen IR
Eur J Immunol; 2000 Apr; 30(4):977-84. PubMed ID: 10760784
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
[TBL] [Abstract][Full Text] [Related]
15. A conserved anti-DNA antibody idiotype associated with nephritis in murine and human systemic lupus erythematosus.
Weisbart RH; Noritake DT; Wong AL; Chan G; Kacena A; Colburn KK
J Immunol; 1990 Apr; 144(7):2653-8. PubMed ID: 2319132
[TBL] [Abstract][Full Text] [Related]
16. The importance of the pathogenic 16/6 idiotype in the induction of SLE in naive mice.
Blank M; Krup M; Mendlovic S; Fricke H; Mozes E; Talal N; Coates AR; Shoenfeld Y
Scand J Immunol; 1990 Jan; 31(1):45-52. PubMed ID: 2405476
[TBL] [Abstract][Full Text] [Related]
17. Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus.
Waisman A; Mozes E
Eur J Immunol; 1993 Jul; 23(7):1566-73. PubMed ID: 8325334
[TBL] [Abstract][Full Text] [Related]
18. A central anti-DNA idiotype in human and murine systemic lupus erythematosus.
Eilat D; Fischel R; Zlotnick A
Eur J Immunol; 1985 Apr; 15(4):368-75. PubMed ID: 3987805
[TBL] [Abstract][Full Text] [Related]
19. The role of anti-idiotypic antibodies in the induction of experimental systemic lupus erythematosus in mice.
Mendlovic S; Fricke H; Shoenfeld Y; Mozes E
Eur J Immunol; 1989 Apr; 19(4):729-34. PubMed ID: 2659371
[TBL] [Abstract][Full Text] [Related]
20. Peptides based on the complementarity-determining regions of a pathogenic autoantibody mitigate lupus manifestations of (NZB x NZW)F1 mice via active suppression.
Zinger H; Eilat E; Meshorer A; Mozes E
Int Immunol; 2003 Feb; 15(2):205-14. PubMed ID: 12578850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
